Acinetobacter baumannii is a leading cause of healthcare-associated infections worldwide.
Because of various intrinsic and acquired mechanisms of resistance, most β-lactam agents …

Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important
cause of resistance of Gram-negative bacteria. The genes encoding for the acquired …

Background Acinetobacter baumannii is a nosocomial pathogen that has emerged as a
major threat in the health-care settings, particularly intensive care units (ICUs). The aim of …

Background Bloodstream infection (BSI) caused by multidrug-resistant Acinetobacter
baumannii (MDR-AB) has been increasingly observed among hospitalized patients. The …

Acinetobacter baumannii is emerging as a pathogen that is commonly involved in
nosocomial infections. A. baumannii has exhibited the ability to develop multidrug resistance …

Background Although the prevalence of the carbapenem-resistant A. baumannii (CRAB) has
increased in Taiwan, few studies have elucidated the prevalence of different …

Acinetobacter baumannii is a prevalent nosocomial pathogen with a high incidence of
multidrug resistance. Treatment of infections due to this organism with colistin, a last-resort …

Abstract Background/Purpose To compare the clinical efficacy between salvage
antimicrobial regimen consisting of tigecycline plus extended-infusion imipenem/cilastatin …

Background Acinetobacter baumannii (AB), an opportunistic pathogen, could develop into
serious infections with high mortality and financial burden. The debate surrounding the …

Static concentration in vitro studies have demonstrated that fosfomycin-or sulbactam-based
combinations may be efficacious against carbapenem-resistant Acinetobacter baumannii …